IDEXX Laboratories Boosts 2023 Revenue Guidance From $3.615B-$3.70B To $3.66B-$3.715B, Consensus $3.67B
Portfolio Pulse from Benzinga Newsdesk
IDEXX Laboratories has increased its 2023 revenue guidance from $3.615B-$3.70B to $3.66B-$3.715B, which is in line with the consensus estimate of $3.67B.
August 01, 2023 | 10:42 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
IDEXX Laboratories has raised its 2023 revenue guidance, which aligns with the consensus estimate. This could potentially boost investor confidence in the company.
IDEXX Laboratories has raised its 2023 revenue guidance to a range that aligns with the consensus estimate. This indicates that the company is confident in its future performance, which could potentially boost investor confidence and positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100